What cancer types does Burning Rock Biotech test for?

Burning Rock Biotech offers tests for lung, gastrointestinal, prostate, breast, lymphoma, thyroid, colorectal, ovarian, pancreatic, and bladder cancers.

What are Burning Rock Biotech's key diagnostic methods?

The company utilizes next-generation sequencing (NGS) for both tissue and liquid biopsy samples.

Which major companies does Burning Rock Biotech collaborate with?

Burning Rock Biotech collaborates with companies including Myriad Genetics, AstraZeneca, Bayer, and Johnson & Johnson.

Home / Health / Burning Rock Biotech Targets Cancer Via Advanced Diagnostics

Burning Rock Biotech Targets Cancer Via Advanced Diagnostics

28 Nov

•

Summary

Develops advanced cancer therapy selection tests.
Offers tests for multiple cancer types via tissue and liquid biopsy.
Collaborates with major pharmaceutical companies on research.

Burning Rock Biotech Limited is at the forefront of developing and commercializing advanced cancer therapy selection tests. Operating in both China and the United States, the company focuses on delivering precise diagnostic solutions across its central laboratory, in-hospital, and pharma R&D services.

Their comprehensive portfolio includes next-generation sequencing tests for numerous cancer types, employing both tissue and liquid biopsy methods. Key products like OncoScreen Plus and OncoCompass Plus aim to identify treatment pathways and predict patient prognosis, revolutionizing cancer care.

Further enhancing its research capabilities, Burning Rock Biotech has forged significant development and commercialization agreements with industry leaders. Collaborations with entities such as Myriad Genetics, AstraZeneca, and Johnson & Johnson underscore its commitment to advancing global cancer diagnostics and treatment.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.